Subcutaneous IL-2 and Low-Dose IFN-α2a in the Treatment of Unselected Patients with Advanced Renal Cell Cancer

1994 ◽  
Vol 17 (3) ◽  
pp. 263-269 ◽  
Author(s):  
I. Funke ◽  
E. Späth-Schwalbe ◽  
G. Stohlmann ◽  
O. Prümmer ◽  
H. Gallati ◽  
...  
Keyword(s):  
Renal Cell Cancer ◽  
Renal Cell ◽  
Low Dose ◽  
Cell Cancer ◽  
Advanced Renal Cell Cancer

scholarly journals Interim Results of a Phase II Study of Sunitinib and Low Dose Metronomic Cyclophosphamide in Advanced Renal Cell Cancer

2012 ◽  
Vol 23 ◽  
pp. ix273-ix274
Author(s):  
M.A. Khattak ◽  
K. Edmonds ◽  
K. Khabra ◽  
A. Sohaib ◽  
K. Pennert ◽  
...  
Keyword(s):  
Phase Ii ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Low Dose ◽  
Phase Ii Study ◽  
Cell Cancer ◽  
Metronomic Cyclophosphamide ◽  
Advanced Renal Cell Cancer

scholarly journals Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review

2006 ◽  
Vol 17 (8) ◽  
pp. 1185-1196 ◽  
Author(s):  
P. Schöffski ◽  
H. Dumez ◽  
P. Clement ◽  
A. Hoeben ◽  
H. Prenen ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitors ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Kinase Inhibitors ◽  
Cell Cancer ◽  
Advanced Renal Cell Cancer

scholarly journals Markers of systemic inflammation predict survival in patients with advanced renal cell cancer

2013 ◽  
Vol 109 (1) ◽  
pp. 147-153 ◽  
Author(s):  
P Fox ◽  
M Hudson ◽  
C Brown ◽  
S Lord ◽  
V Gebski ◽  
...  
Keyword(s):  
Systemic Inflammation ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Cell Cancer ◽  
Advanced Renal Cell Cancer

scholarly journals Reply: Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer

2009 ◽  
Vol 101 (7) ◽  
pp. 1224-1224 ◽  
Author(s):  
A A M van der Veldt ◽  
E Boven ◽  
A J M van den Eertwegh ◽  
J B A G Haanen
Keyword(s):  
Renal Cell Cancer ◽  
Predictive Factors ◽  
Renal Cell ◽  
Cell Cancer ◽  
Severe Toxicity ◽  
Advanced Renal Cell Cancer

Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre study

1989 ◽  
Vol 16 ◽  
pp. 111-113 ◽  
Author(s):  
G. Stoter ◽  
S.D. Fosså ◽  
C. Rugarli ◽  
M. Symann ◽  
C. Jasmin ◽  
...  
Keyword(s):  
Multicentre Study ◽  
Phase Ii ◽  
Renal Cell Cancer ◽  
Renal Cell ◽  
Low Dose ◽  
Cell Cancer ◽  
Interleukin 2 ◽  
Metastatic Renal Cell Cancer

Lack of efficacy of recombinant human interleukin-6 in patients with advanced renal cell cancer: results of a phase II study

1998 ◽  
Vol 34 (5) ◽  
pp. 754-756 ◽  
Author(s):  
M Schuler ◽  
U Bruntsch ◽  
E Späth-Schwalbe ◽  
H Schrezenmeier ◽  
C Peschel ◽  
...  
Keyword(s):  
Phase Ii ◽  
Renal Cell Cancer ◽  
Interleukin 6 ◽  
Renal Cell ◽  
Phase Ii Study ◽  
Cell Cancer ◽  
Advanced Renal Cell Cancer
Sign in / Sign up

Export Citation Format

Share Document